| Serial Number | 79316062 |
| Word Mark | HITMAB |
| Filing Date | Monday, April 26, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 27, 2022 |
| Registration Number | 6854569 |
| Registration Date | Tuesday, September 27, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 12, 2022 |
| Goods and Services | Vaccines; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; pharmaceutical preparations for the prevention and treatment of HIV/AIDS; pharmaceutical preparations for the prevention and treatment of liver diseases; pharmaceutical preparations for the prevention and treatment of respiratory system disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases, diabetes; pharmaceutical preparations for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; drugs for medical purposes for the prevention and treatment of HIV/AIDS; drugs for medical purposes for the prevention and treatment of liver diseases; drugs for medical purposes for the prevention and treatment of respiratory system disorders; drugs for medical purposes for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases and diabetes; drugs for medical purposes for the prevention and treatment of gastro-intestinal diseases; drugs for medical purposes for the prevention and treatment of immune system related diseases and disorders; drugs for medical purposes for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; biological preparations for medical purposes for the prevention and treatment of HIV/AIDS; biological preparations for medical purposes for the prevention and treatment of liver diseases; biological preparations for medical purposes for the prevention and treatment of respiratory system disorders; biological preparations for medical purposes for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases and diabetes; biological preparations for medical purposes for the prevention and treatment of gastro-intestinal diseases; biological preparations for medical purposes for the prevention and treatment of immune system related diseases and disorders; biological preparations for medical purposes for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; medicines for human purposes for the prevention and treatment of HIV/ AIDS; medicines for human purposes for the prevention and treatment of liver diseases; medicines for human purposes for the prevention and treatment of respiratory system disorders; medicines for human purposes for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases and diabetes; medicines for human purposes for the prevention and treatment of gastro-intestinal diseases; medicines for human purposes for the prevention and treatment of immune system related diseases and disorders; medicines for human purposes for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; chemico-pharmaceutical preparations for the treatment of viral and infectious diseases, immune system related diseases, cancer, tumors and inflammation; chemical preparations for pharmaceutical purposes for the treatment of viral and infectious diseases, immune system related diseases, cancer, tumors and inflammation |
| Goods and Services | Retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies |
| Goods and Services | Biological research; research and development of new products for others; scientific laboratory services; scientific research; chemical analysis; conducting clinical trials for others; technological research in the fields of medicine, the prevention, treatment and management of illness, health care delivery; technological research in the fields of genetics, genetic engineering, molecular biology and cellular immunology; conducting technical scientific feasibility project studies; chemistry services, namely, consultation, research and advice; chemical research |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 23, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 23, 2021 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 23, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Zhuhai Trinomab Pharmaceutical Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Party Name | TRINOMAB BIOTECH CO., LTD |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Party Name | TRINOMAB BIOTECH CO., LTD |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Event Date | Event Description |
| Friday, September 22, 2023 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Tuesday, February 7, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, January 18, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, January 18, 2023 | FINAL DISPOSITION PROCESSED |
| Tuesday, December 27, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, September 27, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, September 27, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Monday, July 18, 2022 | NOTIFICATION PROCESSED BY IB |
| Tuesday, July 12, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 12, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 29, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, June 29, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, June 22, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, June 6, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, June 6, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Monday, June 6, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, June 6, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Monday, June 6, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, June 3, 2022 | DATA MODIFICATION COMPLETED |
| Friday, June 3, 2022 | ASSIGNED TO LIE |
| Wednesday, May 25, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, May 24, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, May 24, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, February 6, 2022 | REFUSAL PROCESSED BY IB |
| Tuesday, January 18, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, January 18, 2022 | REFUSAL PROCESSED BY MPU |
| Tuesday, December 28, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, December 27, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, December 22, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, July 27, 2021 | APPLICATION FILING RECEIPT MAILED |
| Friday, July 23, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, July 22, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |